Skip to main content

Ingenuity, Covance Form NGS Data-Analysis Collaboration


Ingenuity Systems said this week that it will partner with Covance Genomics to use Ingenuity's IPA software "to obtain more actionable insights from next-generation sequence data" as well as to "answer research questions in a relevant biological context."

Financial terms of the agreement were not disclosed.

In a statement, Tom Turi, vice president of science and technology in Covance' discovery and translational services group, said that the partners are "confident the combination of our … genomics data and the … biological content and context provided by IPA will result in the delivery of more rapid, accurate, and thorough research services for our customers."

The partnership with Covance marks Ingenuity's second NGS-focused partnership this year.

In January, the firm inked a deal with Erasmus Medical Center allowing the center to use IPA and Ingenuity Knowledgebase to map and contextualize genes and variants related to biological processes, functions, diseases, pathways, compounds, and relationships to "obtain a more complete biological picture from the data." (BI 01/21/2011)

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.